迄今仍缺少治疗流行性乙型脑炎的有效药物，重症患者的病死率和残废率依然很高[1]。作者试用人体高效免疫球蛋白治疗，并以同期其他患者作对照，探讨上述药物对本病的治疗价值。临床资料1．诊断及分型：依据实用内科学有关本病诊断标准，确立本组病例临床诊断及分型[2]。2．病 So far, there is still no effective drug for the treatment of Japanese encephalitis, and the mortality and disability rates of critically ill patients are still high [1]. The trial of human immunoglobulin efficient treatment, and other patients in the same period as a control to explore the value of the above drugs on the disease. Clinical data 1. Diagnosis and classification: According to the practical diagnosis of the disease on the basis of this disease, the establishment of clinical diagnosis and classification of this group of patients [2]. 2. disease